PCDH9 suppresses melanoma proliferation and cell migration

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Melanoma incidence has risen significantly over the past 30 years.
• Melanoma is characterized by low survival and prognosis rates.
• Understanding the molecular mechanisms underlying melanoma progression is crucial.

Purpose of the Study:

• To investigate the role of Protocadherin 9 (PCDH9) in melanoma.
• To assess the impact of PCDH9 alteration on melanoma cell behavior.
• To explore PCDH9 as a potential prognostic and therapeutic target for melanoma.

Main Methods:

• Utilized melanoma cell lines (A375, G361) as an in vitro model.
• Employed immunohistochemistry (IHC) and bioinformatics for PCDH9 analysis.
• Manipulated PCDH9 expression (interference and overexpression) using lentivirus.
• Assessed effects on cell viability, apoptosis, cell cycle, and migration.
• Quantified gene expression of PCDH9, MMP2, MMP9, CCND1, and RAC1 via PCR.

Main Results:

• PCDH9 expression was suppressed in melanoma cells.
• Altered PCDH9 levels correlated negatively with MMP2, MMP9, and RAC1, and positively with CCND1 and apoptosis.
• Increased PCDH9 suppressed melanoma cell viability and migration but did not significantly affect the cell cycle.
• IHC revealed lower PCDH9 expression in melanoma tissues, primarily in the cytoplasm.

Conclusions:

• Overexpression of PCDH9 effectively suppressed melanoma cells.
• PCDH9 demonstrates potential as an independent prognostic factor for melanoma.
• Re-expression of PCDH9 presents a promising therapeutic strategy for melanoma treatment.